Live Breaking News & Updates on Cyteir Therapeutics Inc

Stay updated with breaking news from Cyteir therapeutics inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Cyteir Therapeutics Reports First Quarter 2023 Financial Results and Operational Highlights

Cyteir Therapeutics Reports First Quarter 2023 Financial Results and Operational Highlights
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United States , Markus Renschler , Clinical Program , Cyteir Therapeutics Inc , American Society Of Clinical Oncology , Exchange Commission , Chief Executive Officer , American Society , Clinical Oncology , Developmental Therapeutics , Molecularly Targeted Agents , Tumor Biology , Cyteir Therapeutics , Annual Report , Months Ended March ,

Repare Therapeutics Appoints Susan Molineaux, Ph.D., to Its Board of Directors

Repare Therapeutics Inc. , a leading clinical-stage precision oncology company, today announced the appointment of Susan Molineaux, Ph.D., to its Board of Directors, effective as of the date of the. | April 28, 2023 ....

Lloydm Segal , Susan Molineaux , Jerel Davis , Johns Hopkins University , Company Nasdaq , Onyx Pharmaceuticals Inc , Para Therapeutics Inc , Smith College , Repare Therapeutics Inc , Columbia University , Calithera Biosciences Inc , Rigel Pharmaceuticals Inc , Merck Co , Cyteir Therapeutics Inc , Company Board , Boards Of Directors Geron Corp , Proteolix Inc , Repare Therapeutics , Managing Director , Versant Ventures , Chief Executive Officer , Calithera Biosciences , Chief Scientific Officer , Onyx Pharmaceuticals , Rigel Pharmaceuticals , Geron Corp ,

Repare Therapeutics Appoints Susan Molineaux, Ph.D., to Its Board of Directors

Repare Therapeutics Appoints Susan Molineaux, Ph.D., to Its Board of Directors
financialpost.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from financialpost.com Daily Mail and Mail on Sunday newspapers.

Columbia University , New York , United States , United Kingdom , Lloydm Segal , Susan Molineaux , David Rosen , Matthew Deyoung , Jerel Davis , Merck Co , Proteolix Inc , Rigel Pharmaceuticals Inc , Smith College , Company Board , Johns Hopkins University , Postmedia Network Inc , Onyx Pharmaceuticals Inc , Repare Therapeutics Inc , Calithera Biosciences Inc , Cyteir Therapeutics Inc , Exchange Commission , Company Annual Report On Form , Para Therapeutics Inc , Company Nasdaq , Boards Of Directors Geron Corp , National Post ,

Cyteir Therapeutics Reports Fourth Quarter and Full Year 2022 Financial Results and Operational Highlights

Initial data from Phase 1 combination with capecitabine in advanced ovarian cancer are expected in mid-2023

Dose for the Phase 1 combination trials identified as 400mg daily

Ended 2022 with. | March 23, 2023 ....

Markus Renschler , Cyteir Therapeutics Inc , Exchange Commission , Clinical Program , Cyteir Therapeutics , Chief Executive Officer , Full Year , Annual Report , Months Ended December , Ended December , Nc Stock Exchange , Press Release , 022 Cyt Us23284p1030 ,

Cyteir Therapeutics Promotes David Gaiero to Chief Financial Officer

Cyteir Therapeutics, Inc. a clinical stage oncology company today announced the promotion of David Gaiero to Chief Financial Officer . David was previously Vice President of Finance at Cyteir. As. | February 6, 2023 ....

United States , University Of Massachusetts , Markus Renschler , David Gaiero , Robot Corporation , Ovascience Inc , Cyteir Therapeutics Inc , Wave Life Sciences , Cyteir Therapeutics , Chief Financial Officer , Vice President , Chief Executive Officer , Interim Chief Financial Officer , Corporate Controller , Global Controller , Certified Public Accountant , Nc Stock Exchange , Press Release , T Cyt Us23284p1030 ,